Symbols / VVOS $1.31 -0.76% Vivos Therapeutics, Inc.

Healthcare • Medical Devices • United States • NCM
VVOS Chart
About

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 14.96M
Enterprise Value 21.28M Income -17.10M Sales 17.32M
Book/sh 0.31 Cash/sh 0.34 Dividend Yield —
Payout 0.00% Employees 262 IPO —
P/E — Forward P/E -1.05 PEG —
P/S 0.86 P/B 4.28 P/C —
EV/EBITDA -1.39 EV/Sales 1.23 Quick Ratio 0.70
Current Ratio 0.78 Debt/Eq 493.60 LT Debt/Eq —
EPS (ttm) -1.77 EPS next Y -1.25 EPS Growth —
Revenue Growth 75.70% Earnings 2026-04-14 ROA -49.76%
ROE -3.35% ROIC — Gross Margin 55.73%
Oper. Margin -69.79% Profit Margin -98.76% Shs Outstand 10.47M
Shs Float 7.21M Short Float 5.07% Short Ratio 5.83
Short Interest — 52W High 7.95 52W Low 1.08
Beta 6.90 Avg Volume 120.17K Volume 2.80M
Target Price $5.00 Recom Buy Prev Close $1.32
Price $1.31 Change -0.76%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.00
Mean price target
2. Current target
$1.31
Latest analyst target
3. DCF / Fair value
$-16.13
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.31
Low
$2.50
High
$7.00
Mean
$5.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-03 main Ascendiant Capital Buy → Buy $6
2025-11-17 init HC Wainwright & Co. — → Buy $7
2025-09-09 main Ascendiant Capital Buy → Buy $7
2025-04-15 main Ascendiant Capital Buy → Buy $6
2024-11-20 reit Ascendiant Capital Buy → Buy $7
2024-11-19 main Alliance Global Partners Buy → Buy $6
2024-08-20 main Ascendiant Capital Buy → Buy $7
News
RSS: Latest VVOS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
15.03
+8.91%
13.80
-13.87%
16.02
-5.10%
16.89
Operating Revenue
15.03
+8.91%
13.80
-13.87%
16.02
-5.10%
16.89
Cost Of Revenue
6.01
+8.72%
5.53
-7.91%
6.00
+40.27%
4.28
Reconciled Cost Of Revenue
6.01
+8.72%
5.53
-7.91%
6.00
+40.27%
4.28
Gross Profit
9.02
+9.04%
8.27
-17.45%
10.02
-20.51%
12.60
Operating Expense
20.19
-21.03%
25.57
-27.06%
35.05
+9.28%
32.08
Selling General And Administration
19.61
-21.39%
24.95
-27.44%
34.38
+9.70%
31.34
Selling And Marketing Expense
1.73
-29.83%
2.47
-53.80%
5.34
-3.80%
5.55
General And Administrative Expense
17.88
-20.47%
22.48
-22.60%
29.04
+12.60%
25.79
Other Gand A
17.88
-20.47%
22.48
-22.60%
29.04
+12.60%
25.79
Total Expenses
26.20
-15.74%
31.10
-24.26%
41.05
+12.92%
36.36
Operating Income
-11.17
+35.41%
-17.30
+30.90%
-25.03
-28.56%
-19.47
Total Operating Income As Reported
-11.17
+35.41%
-17.30
+30.90%
-25.03
-22.81%
-20.38
EBITDA
-10.59
+36.49%
-16.68
+31.55%
-24.36
-24.67%
-19.54
Normalized EBITDA
-10.59
+48.22%
-20.45
+20.26%
-25.65
-37.68%
-18.63
Reconciled Depreciation
0.58
-6.44%
0.62
-7.17%
0.67
-8.73%
0.73
EBIT
-11.17
+35.41%
-17.30
+30.90%
-25.03
-23.46%
-20.27
Total Unusual Items
—
3.78
+193.55%
1.29
+241.27%
-0.91
Total Unusual Items Excluding Goodwill
—
3.78
+193.55%
1.29
+241.27%
-0.91
Special Income Charges
—
0.00
-100.00%
1.29
+241.27%
-0.91
Other Special Charges
—
—
-1.29
—
Write Off
—
—
0.00
-100.00%
0.91
Net Income
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Pretax Income
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Net Non Operating Interest Income Expense
—
—
0.00
+100.00%
-0.01
Interest Expense Non Operating
—
—
0.00
-100.00%
0.01
Net Interest Income
—
—
0.00
+100.00%
-0.01
Interest Expense
—
—
0.00
-100.00%
0.01
Interest Income Non Operating
—
—
—
0.12
Interest Income
—
—
—
0.12
Other Income Expense
0.04
-99.06%
3.71
+213.07%
1.19
+247.70%
-0.80
Other Non Operating Income Expenses
0.04
+153.85%
-0.07
+35.64%
-0.10
-193.52%
0.11
Gain On Sale Of Security
—
3.78
—
—
Tax Provision
—
—
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Net Income From Continuing Operation Net Minority Interest
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Net Income From Continuing And Discontinued Operation
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Net Income Continuous Operations
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Normalized Income
-11.14
+35.86%
-17.36
+30.92%
-25.13
-29.70%
-19.38
Net Income Common Stockholders
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-2.22
+80.07%
-11.14
+56.99%
-25.90
-7.92%
-24.00
Basic EPS
-2.22
+80.07%
-11.14
+56.99%
-25.90
-7.92%
-24.00
Basic Average Shares
5.02
+311.67%
1.22
+32.46%
0.92
+8.39%
0.85
Diluted Average Shares
5.02
+311.67%
1.22
+32.46%
0.92
+8.39%
0.85
Diluted NI Availto Com Stockholders
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Depreciation Amortization Depletion Income Statement
0.58
-6.44%
0.62
-7.17%
0.67
-8.73%
0.73
Depreciation And Amortization In Income Statement
0.58
-6.44%
0.62
-7.17%
0.67
-8.73%
0.73
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
15.28
+42.44%
10.73
-21.79%
13.72
-59.27%
33.69
Current Assets
7.47
+203.66%
2.46
-54.63%
5.42
-80.15%
27.32
Cash Cash Equivalents And Short Term Investments
6.26
+281.01%
1.64
-53.31%
3.52
-85.36%
24.03
Cash And Cash Equivalents
6.26
+281.01%
1.64
-53.31%
3.52
-85.36%
24.03
Receivables
0.43
+112.87%
0.20
-55.80%
0.46
-73.41%
1.72
Accounts Receivable
0.43
+112.87%
0.20
-55.80%
0.46
-62.01%
1.20
Gross Accounts Receivable
0.82
+74.47%
0.47
-59.79%
1.17
-15.47%
1.38
Allowance For Doubtful Accounts Receivable
-0.39
-45.52%
-0.27
+62.36%
-0.71
-295.56%
-0.18
Other Receivables
—
—
—
0.52
Prepaid Assets
—
—
—
1.57
Other Current Assets
0.78
+27.11%
0.62
-57.46%
1.45
-8.06%
1.57
Total Non Current Assets
7.81
-5.54%
8.27
-0.33%
8.30
+30.34%
6.37
Net PPE
4.38
-6.75%
4.70
-1.63%
4.78
+69.10%
2.83
Gross PPE
7.24
+3.06%
7.03
+7.58%
6.53
+60.52%
4.07
Accumulated Depreciation
-2.86
-22.87%
-2.33
-32.69%
-1.75
-41.03%
-1.24
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.35
+2.12%
1.32
+4.43%
1.26
-9.25%
1.39
Construction In Progress
1.86
+29.41%
1.44
+51.37%
0.95
+347.17%
0.21
Other Properties
1.55
-13.13%
1.79
-2.61%
1.84
+2350.67%
0.07
Leases
2.48
+0.00%
2.48
+0.00%
2.48
+3.85%
2.39
Goodwill And Other Intangible Assets
3.21
-1.53%
3.26
+3.75%
3.15
-1.22%
3.18
Goodwill
2.84
+0.00%
2.84
+0.00%
2.84
+0.00%
2.84
Other Intangible Assets
0.37
-11.90%
0.42
+39.07%
0.30
-11.44%
0.34
Non Current Prepaid Assets
—
—
0.37
+5.06%
0.36
Other Non Current Assets
0.22
-29.64%
0.31
-17.91%
0.37
—
Total Liabilities Net Minority Interest
7.33
-28.97%
10.32
+15.70%
8.92
+9.44%
8.15
Current Liabilities
4.98
-31.71%
7.29
+6.99%
6.81
-9.27%
7.51
Payables And Accrued Expenses
3.33
-25.61%
4.48
+34.79%
3.32
-11.93%
3.77
Payables
1.58
-36.12%
2.47
+75.19%
1.41
+53.37%
0.92
Accounts Payable
1.10
-48.81%
2.15
+52.02%
1.41
+53.37%
0.92
Current Accrued Expenses
1.75
-12.66%
2.01
+4.97%
1.91
-32.98%
2.85
Employee Benefits
1.22
+0.00%
1.22
0.00
—
Total Tax Payable
0.48
+47.09%
0.33
—
—
Current Debt And Capital Lease Obligation
0.48
+0.63%
0.47
+13.13%
0.42
-68.59%
1.33
Current Debt
—
—
—
1.26
Other Current Borrowings
—
—
—
1.26
Current Capital Lease Obligation
0.48
+0.63%
0.47
+13.13%
0.42
+507.25%
0.07
Current Deferred Liabilities
0.90
-58.09%
2.14
-26.93%
2.93
+21.82%
2.40
Current Deferred Revenue
0.90
-58.09%
2.14
-26.93%
2.93
+21.97%
2.40
Other Current Liabilities
0.27
+37.88%
0.20
+36.55%
0.14
-68.88%
0.47
Total Non Current Liabilities Net Minority Interest
2.35
-22.38%
3.03
+43.87%
2.11
+228.55%
0.64
Long Term Debt And Capital Lease Obligation
1.03
-31.95%
1.52
-23.72%
1.99
+569.13%
0.30
Long Term Capital Lease Obligation
1.03
-31.95%
1.52
-23.72%
1.99
+569.13%
0.30
Non Current Deferred Liabilities
0.10
-66.44%
0.29
+158.04%
0.11
-67.35%
0.34
Non Current Deferred Revenue
0.10
-66.44%
0.29
+158.04%
0.11
0.00
Stockholders Equity
7.95
+1835.28%
0.41
-91.44%
4.80
-81.20%
25.54
Common Stock Equity
7.95
+1835.28%
0.41
-91.44%
4.80
-81.20%
25.54
Capital Stock
0.00
0.00
0.00
-100.00%
0.00
Common Stock
0.00
0.00
0.00
-100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
5.89
+221.15%
1.83
+99.23%
0.92
+0.00%
0.92
Ordinary Shares Number
5.89
+221.15%
1.83
+99.23%
0.92
+0.00%
0.92
Additional Paid In Capital
112.14
+19.99%
93.46
+10.91%
84.27
+3.83%
81.16
Retained Earnings
-104.19
-11.97%
-93.05
-17.09%
-79.47
-42.87%
-55.62
Total Equity Gross Minority Interest
7.95
+1835.28%
0.41
-91.44%
4.80
-81.20%
25.54
Total Capitalization
7.95
+1835.28%
0.41
-91.44%
4.80
-81.20%
25.54
Working Capital
2.50
+151.68%
-4.83
-247.59%
-1.39
-107.01%
19.82
Invested Capital
7.95
+1835.28%
0.41
-91.44%
4.80
-82.09%
26.80
Total Debt
1.51
-24.21%
2.00
-17.32%
2.41
+47.86%
1.63
Capital Lease Obligations
1.51
-24.21%
2.00
-17.32%
2.41
+557.49%
0.37
Net Tangible Assets
4.74
+266.23%
-2.85
-272.22%
1.66
-92.59%
22.36
Tangible Book Value
4.74
+266.23%
-2.85
-272.22%
1.66
-92.59%
22.36
Dueto Related Parties Current
—
—
—
0.00
Non Current Note Receivables
—
—
—
0.00
Notes Receivable
—
—
—
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-12.69
-6.24%
-11.95
+39.01%
-19.59
-24.48%
-15.73
Cash Flow From Continuing Operating Activities
-12.69
-6.24%
-11.95
+39.01%
-19.59
-24.48%
-15.73
Net Income From Continuing Operations
-11.14
+18.02%
-13.58
+43.04%
-23.84
-17.53%
-20.29
Depreciation Amortization Depletion
0.58
-6.44%
0.62
-7.17%
0.67
-8.73%
0.73
Depreciation And Amortization
0.58
-6.44%
0.62
-7.17%
0.67
-8.73%
0.73
Other Non Cash Items
0.01
-87.36%
0.09
—
-0.01
Stock Based Compensation
0.76
-31.10%
1.11
-53.84%
2.40
-9.86%
2.66
Asset Impairment Charge
—
—
0.00
-100.00%
0.91
Operating Gains Losses
0.03
+101.02%
-3.04
-487.07%
-0.52
-323.28%
0.23
Gain Loss On Investment Securities
0.03
+101.02%
-3.04
-527.71%
0.71
+206.47%
0.23
Change In Working Capital
-2.94
-202.65%
2.86
+67.39%
1.71
+6010.71%
0.03
Change In Receivables
-0.23
-189.41%
0.26
-65.82%
0.75
+227.19%
0.23
Changes In Account Receivables
-0.23
-189.41%
0.26
-65.82%
0.75
+227.19%
0.23
Change In Prepaid Assets
-0.06
-106.80%
0.91
+729.09%
0.11
+111.59%
-0.95
Change In Payables And Accrued Expense
-1.09
-194.03%
1.16
+356.89%
-0.45
-135.83%
1.26
Change In Accrued Expense
-0.04
-109.24%
0.42
+144.85%
-0.94
-184.24%
1.12
Change In Payable
-1.05
-242.78%
0.73
+49.49%
0.49
+253.24%
0.14
Change In Account Payable
-1.05
-242.78%
0.73
+49.49%
0.49
+253.24%
0.14
Change In Other Working Capital
-1.43
-134.70%
-0.61
-152.95%
1.15
+327.61%
-0.51
Change In Other Current Liabilities
-0.13
-111.20%
1.15
+662.91%
0.15
0.00
Investing Cash Flow
-0.57
+33.41%
-0.85
+7.68%
-0.92
+64.57%
-2.61
Cash Flow From Continuing Investing Activities
-0.57
+33.41%
-0.85
+7.68%
-0.92
+64.57%
-2.61
Net PPE Purchase And Sale
-0.57
+29.27%
-0.80
+13.10%
-0.92
+61.44%
-2.40
Purchase Of PPE
-0.57
+29.27%
-0.80
+13.10%
-0.92
+61.44%
-2.40
Capital Expenditure
-0.57
+29.27%
-0.80
+13.10%
-0.92
+61.44%
-2.40
Net Business Purchase And Sale
—
—
0.00
+100.00%
-0.23
Purchase Of Business
—
—
0.00
+100.00%
-0.23
Net Other Investing Changes
—
-0.05
—
0.01
Financing Cash Flow
17.88
+63.65%
10.92
0.00
-100.00%
24.17
Cash Flow From Continuing Financing Activities
17.88
+63.65%
10.92
0.00
-100.00%
24.17
Net Issuance Payments Of Debt
—
—
0.00
+100.00%
-0.03
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
0.00
+100.00%
-0.03
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
0.00
+100.00%
-0.03
Net Long Term Debt Issuance
—
—
0.00
+100.00%
-0.03
Net Common Stock Issuance
7.80
+94.90%
4.00
0.00
-100.00%
27.93
Repurchase Of Capital Stock
—
—
0.00
+100.00%
-1.50
Proceeds From Stock Option Exercised
11.44
+43.01%
8.00
—
—
Net Other Financing Charges
-1.36
-26.37%
-1.08
—
-2.24
Changes In Cash
4.62
+346.11%
-1.88
+90.85%
-20.51
-452.18%
5.82
Beginning Cash Position
1.64
-53.31%
3.52
-85.36%
24.03
+31.99%
18.21
End Cash Position
6.26
+281.01%
1.64
-53.31%
3.52
-85.36%
24.03
Free Cash Flow
-13.26
-4.00%
-12.75
+37.84%
-20.51
-13.13%
-18.13
Interest Paid Supplemental Data
0.01
0.00
0.00
-100.00%
0.02
Income Tax Paid Supplemental Data
—
—
—
0.00
Common Stock Issuance
7.80
+94.90%
4.00
0.00
-100.00%
27.93
Issuance Of Capital Stock
7.80
+94.90%
4.00
0.00
-100.00%
27.93
Net Preferred Stock Issuance
—
—
0.00
+100.00%
-1.50
Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Payments
—
—
0.00
+100.00%
-1.50
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category